Estija - estų - Ravimiamet

orion corporation - propafenoon - õhukese polümeerikattega tablett - 300mg 50tk; 300mg 20tk; 300mg 60tk; 300mg 100tk; 300mg 90tk

Estija - estų - Ravimiamet

teva pharma b.v. - atorvastatiin+amlodipiin - õhukese polümeerikattega tablett - 10mg+10mg 28tk; 10mg+10mg 90tk; 10mg+10mg 30tk; 10mg+10mg 100tk

Estija - estų - Ravimiamet

teva pharma b.v. - atorvastatiin+amlodipiin - õhukese polümeerikattega tablett - 10mg+5mg 28tk; 10mg+5mg 90tk; 10mg+5mg 100tk

Estija - estų - Ravimiamet

teva pharma b.v. - atorvastatiin+amlodipiin - õhukese polümeerikattega tablett - 10mg+10mg 28tk; 10mg+10mg 100tk

Estija - estų - Ravimiamet

teva pharma b.v. - atorvastatiin+amlodipiin - õhukese polümeerikattega tablett - 10mg+5mg 100tk; 10mg+5mg 90tk; 10mg+5mg 30tk; 10mg+5mg 28tk

Europos Sąjunga - estų - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib dietüülfumaraat - leukeemia, müeloidne, äge - antineoplastilised ained - xospata on näidustatud monotherapy raviks täiskasvanud patsientidel, kes on taastekkinud või tulekindlad ägeda müeloidse leukeemia (aml), mille flt3 mutatsioon.

Europos Sąjunga - estų - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - hulgiskleroos - muud närvisüsteemi ravimid - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Europos Sąjunga - estų - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artriit, reumatoidartriit - immunosupressandid - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Europos Sąjunga - estų - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomüoom - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Europos Sąjunga - estų - EMA (European Medicines Agency)

accord healthcare s.l.u. - relugolix - eesnäärmevähk - endokriinset ravi - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.